van MEEL; Jacobus C.A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for van MEEL; Jacobus C.A..The latest application filed is for "quinazoline derivatives for the treatment of cancer diseases".

Company Profile

0.22.25

van MEEL; Jacobus C.A. - Moedling AT
van Meel; Jacobus C. A. - Mittelbiberach DE
van Meel; Jacobus C. A. - Biberach DE
van Meel; Jacobus C. A. - Amsterdam NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20180360834 - SOLCA; Flavio ; et al.	2018-12-20
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20180086744 - SOLCA; Flavio ; et al.	2018-03-29
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20170112835 - SOLCA; Flavio ; et al.	2017-04-27
Quinazoline derivatives for the treatment of cancer diseases Grant 9,539,258 - Solca , et al. January 10, 2	2017-01-10
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20150272954 - SOLCA; Flavio ; et al.	2015-10-01
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20150265610 - STEFANIC; Martin Friedrich ; et al.	2015-09-24
Quinazoline derivatives for the treatment of cancer diseases Grant 9,089,571 - Solca , et al. July 28, 2	2015-07-28
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20140199298 - SOLCA; Flavio ; et al.	2014-07-17
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20140057898 - STEFANIC; Martin Friedrich ; et al.	2014-02-27
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20130178487 - SOLCA; Flavio ; et al.	2013-07-11
Quinazoline derivatives for the treatment of cancer diseases Grant 8,404,697 - Solca , et al. March 26, 2	2013-03-26
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20110171289 - STEFANIC; Martin Friedrich ; et al.	2011-07-14
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20110136826 - HILBERG; Frank ; et al.	2011-06-09
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells, Or Angiogenesis App 20110039863 - HILBERG; Frank ; et al.	2011-02-17
Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments Grant 7,858,616 - Roth , et al. December 28, 2	2010-12-28
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis Grant 7,846,936 - Hilberg , et al. December 7, 2	2010-12-07
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20090306101 - Solca; Flavio ; et al.	2009-12-10
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20090306044 - Solca; Flavio ; et al.	2009-12-10
Indolinone Derivatives Substituted In The 6 Position, Their Preparation And Their Use As Medicaments App 20090197876 - ROTH; Gerald Juergen ; et al.	2009-08-06
Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments Grant 7,547,703 - Roth , et al. June 16, 2	2009-06-16
Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions Grant 7,514,468 - Heckel , et al. April 7, 2	2009-04-07
Combinations For The Treatment Of Diseases Involving Cell Proliferation, Migration Or Apoptosis Of Myeloma Cells Or Angiogenesis App 20080254040 - STEFANIC; Martin Friedrich ; et al.	2008-10-16
Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments Grant 7,169,936 - Roth , et al. January 30, 2	2007-01-30
Indoline Derivatives Substituted In The 6 Position, Their Preparation And Their Use As Medicaments App 20070004757 - Roth; Gerald Juergen ; et al.	2007-01-04
Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments Grant 7,148,249 - Kley , et al. December 12, 2	2006-12-12
Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions App 20060194813 - Heckel; Armin ; et al.	2006-08-31
Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments App 20050054710 - Kley, Joerg ; et al.	2005-03-10
Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments App 20050043389 - Roth, Gerald Juergen ; et al.	2005-02-24
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis App 20050043233 - Stefanic, Martin Friedrich ; et al.	2005-02-24
Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs Grant 6,855,710 - Walter , et al. February 15, 2	2005-02-15
New substituted indolinones, their manufacture and their use as medicaments App 20050009898 - Roth, Gerald Juergen ; et al.	2005-01-13
Substituted indolinones, their manufacture and their use as medicaments Grant 6,794,395 - Roth , et al. September 21, 2	2004-09-21
Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs App 20040058978 - Walter, Rainer ; et al.	2004-03-25
Substituted indolinones with kinase inhibitory activity Grant 6,319,918 - Heckel , et al. November 20, 2	2001-11-20
Indolinones having kinase inhibitory activity Grant 6,169,106 - Heckel , et al. January 2, 2	2001-01-02
(Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists Grant 5,602,127 - Hauel , et al. February 11, 1	1997-02-11
Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biph enyls useful as angiotensin-II antagonists Grant 5,594,003 - Hauel , et al. January 14, 1	1997-01-14
Benzimidazoles useful as angiotensin-11 antagonists Grant 5,591,762 - Hauel , et al. January 7, 1	1997-01-07
2-phenyl-imidazopyridin-ones and also useful as cardiotonics and anti-hypertensives Grant 4,766,130 - Austel , et al. August 23, 1	1988-08-23
Novel 2-phenyl-imidazoles and pharmaceutical compositions containing same Grant 4,722,929 - Austel , et al. * February 2, 1	1988-02-02
Imidazo[4,5-c]pyridazine-3-ones, imidazo[4,5-d]pyridazine-4-ones, imidazo[4,]pyrazin-5-ones, purin-2-ones, purin-6-ones, and purin-2,6-diones useful as hypotensive or cardiotonic agents Grant 4,670,438 - Austel , et al. June 2, 1	1987-06-02
Pharmaceutical composition for the treatment of glaucoma Grant 4,400,378 - Innemee , et al. August 23, 1	1983-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.